Detalhe da pesquisa
1.
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy.
Cell
; 178(3): 521-535.e23, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31348885
2.
Transplanted organoids empower human preclinical assessment of drug candidate for the clinic.
Sci Adv
; 8(27): eabj5633, 2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857479
3.
TRPC5 Channel Inhibition Protects Podocytes in Puromycin-Aminonucleoside Induced Nephrosis Models.
Front Med (Lausanne)
; 8: 721865, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34621762
4.
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic.
bioRxiv
; 2020 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32637960
5.
A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury.
Cell Rep Med
; 1(8): 100137, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33294858
6.
Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation.
Nat Commun
; 10(1): 5462, 2019 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31784515